Shell Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,298
Closed -$45K 1410
2021
Q2
$45K Sell
1,298
-1,451
-53% -$47.9K ﹤0.01% 1452
2021
Q1
$81K Sell
2,749
-730
-21% -$22.4K ﹤0.01% 1323
2020
Q4
$107K Buy
3,479
+1,296
+59% +$39.5K ﹤0.01% 1259
2020
Q3
$61K Hold
2,183
﹤0.01% 1242
2020
Q2
$47K Sell
2,183
-11,226
-84% -$248K ﹤0.01% 1249
2020
Q1
$300K Hold
13,409
0.01% 869
2019
Q4
$395K Sell
13,409
-5,167
-28% -$140K 0.01% 966
2019
Q3
$494K Hold
18,576
0.01% 895
2019
Q2
$628K Buy
18,576
+8,020
+76% +$260K 0.01% 809
2019
Q1
$339K Buy
+10,556
New +$325K 0.01% 1026

Other funds holding ELAN

Shell Asset Management's ELAN Position: Q3 2021 in Review

Shell Asset Management sold out of Elanco Animal Health (ELAN) in Q3 2021, closing a stake of 1,298 shares — an estimated $45K sold.

Shell Asset Management first reported a position in ELAN in Q1 2019 and held it in 10 quarters. The position peaked at $628K in Q2 2019. 453 funds tracked by Wall St. Rank hold ELAN as of Q3 2021.

  • Shell Asset Management reported no remaining Elanco Animal Health position as of Q3 2021 after selling out during the quarter.
  • Shell Asset Management sold 1,298 Elanco Animal Health shares in Q3 2021, an estimated $45K.
  • Shell Asset Management first reported a position in Elanco Animal Health in Q1 2019 and held it in 10 quarters.
  • Shell Asset Management's Elanco Animal Health position peaked at $628K in Q2 2019.
  • 453 funds tracked by Wall St. Rank held Elanco Animal Health as of Q3 2021.

Based on Shell Asset Management's 13F filing for Q3 2021, filed 4 Nov 2021.